Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
CC transcript
|
|
CATALYST BIOSCIENCES, INC. (CBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 1.4% stake in Catalyst Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in Catalyst Biosciences, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in Catalyst Biosciences Inc. |
| 02/14/2022 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8.8% stake in Catalyst Biosciences, Inc. |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Catalyst Biosciences, Inc. |
| 02/18/2021 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 6.9% stake in Catalyst Biosciences, Inc. |
| 02/12/2021 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 3.8% stake in Catalyst Biosciences, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
SC 13G/A
| Mangrove Partners Master Fund, Ltd. reports a 0% stake in Catalyst Biosciences, Inc. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| Mangrove Partners Master Fund, Ltd. reports a 5.7% stake in Catalyst Biosciences, Inc. |
| 01/17/2020 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 6% stake in CATALYST BIOSCIENCES, INC. |
| 07/10/2019 |
SC 13G/A
| BlackRock Inc. reports a 2.3% stake in CATALYST BIOSCIENCES, INC. |
| 02/14/2019 |
SC 13G/A
| NEXTHERA CAPITAL LP reports a 3.1% stake in Catalyst Biosciences, Inc. |
| 02/14/2019 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2019 |
SC 13G/A
| RTW INVESTMENTS, LLC has filed a Schedule 13D for Catalyst Biosciences, Inc. |
| 02/12/2019 |
SC 13G/A
| Flynn James E reports a 0% stake in Catalyst Biosciences, Inc. |
| 02/11/2019 |
SC 13G/A
| JFL Capital Management, LLC reports a 7% stake in Catalyst Biosciences, Inc. |
| 05/24/2018 |
SC 13G/A
| NEXTHERA CAPITAL LP reports a 4.8% stake in Catalyst Biosciences, Inc. |
| 04/16/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| LYTTON LAURENCE W reports a 1.2% stake in Catalyst Biosciences, Inc. |
| 01/22/2018 |
SC 13G/A
| JOHNSON & JOHNSON reports a 1.6% stake in Catalyst Biosciences, Inc. |
| 05/01/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/09/2016 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 2.7% stake in Catalyst Biosciences, Inc. |
| 09/10/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 11/16/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 09/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|
|